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S100B is a calcium binding protein expressed and secreted by astrocytes. Extracellular S100B stimulates the proliferation of astroglial cells and the survival of neurons. Extracellular signal regulated kinases (ERK) are involved in the transduction of proliferating signals in astrocytes. Here we report that S100B signi®cantly increases the activity of ERK in primary cultures of astrocytes, a result which may be related to previous observations of the effect of this protein on glial proliferation. We further con®rm that conversion of S100B to its covalent dimer by oxidation of cysteine residues increases its extracellular activity. Although we cannot exclude S100B involvement in other mechanisms of signal transduction, these results suggest that ERK activity in astrocytes is modulated by extracellular INTRODUCTION S100B is a calcium-binding protein expressed primarily in astroglial cells and secreted by these cells [1] . The protein is a homodimer of 21 kDa, although its dimerization is not calcium or sulphydryl dependent [2] . Many studies have suggested an intracellular role for S100B particularly in the regulation of the cytoskeleton [3, 4] , and an increasing number of reports point to the importance of its extracellular role [5] . Extracellular S100B stimulates the proliferation of astrocytes and C6 glioma cells [6] and the survival and extension of neurites in primary cultures of neurons. These actions of S100B depend on the presence of cysteine residues 68 and 84 [7] and on the oxidation state of these residues [6, 8] . In addition to its trophic actions, S100B can induce apoptosis in neurons and astrocytes [9, 10] . There are, however, many unsolved questions about extracellular trophic and apoptotic actions of S100B, including its mechanism of signal transduction [5] .
It is of interest to note that the gene for human S100B maps to the region of chromosome 21 which is abnormal in Down's syndrome and a high level of S100B protein has been described in the brains of patients with this syndrome [11] . The protein is also increased in the brain in Alzheimer's disease [11, 12] . These observations support a potential involvement of S100B in the pathology of these neurodegenerative disorders [13] .
A subtype of the mitogen activated protein kinase (MAPK) [14] called extracellular signal regulated protein kinase (ERK) is involved in mediating the signals of proliferation in astrocytes [15] [16] [17] . The cascade is composed of three main kinases (cRaf-1, MEK1 and ERK1/2) which phosphorylate and activate the next component in the cascade. ERK is activated by the phosphorylation of threonine and tyrosine residues. In this study we report that extracellular S100B activates ERK in primary cultures of astrocytes.
MATERIALS AND METHODS
Primary astrocytes were obtained from neonatal rat cerebral hippocampi as previously described [18] . Experiments were conducted with 3-week-old cultures, which consisted of . 95% astrocytes [18] . Prior to treatment, cells were shifted from a medium containing Dulbecco's modi®ed Eagle's medium (DMEM) with 10% fetal calf serum (FCS) to DMEM containing 0.5% FCS for 48 h. S100B was purchased from Sigma and its oxidized form was obtained by treatment with 5 mM sodium tetrathionate for 30 min, as described by Scotto et al. [8] . Oxidation of S100B was evaluated by running samples in 10% SDS±PAGE gels (in the presence and absence of 50 mM DTT), according to the method of Scha Ègger and Jagow [19] . After oxidation about 50±60% of S100B consisted of disul®de-bonded dimers, differently from non-oxidized form where only about 10± 15% was found as covalent dimers. Fibroblast growth factor-2 was purchased from R and D systems.
ERK activation was determined by two methods. First, immunoblots derived from samples incubated with and without S100B, were probed with an antibody which recognizes dually phosphorylated (Thr 183 and Tyr 185 ) ERK1/2 (New England Biolabs, Inc.). Membranes of nitrocellulose were incubated with a blocking solution consisting of Tris-buffered saline containing 5% non-fat dry milk and 0.05% Tween 20. The blots were incubated with antiphospho ERK1/2 antibodies (1/2000) and then with peroxidase-conjugated anti-rabbit IgG (1/1000) (Amersham Life Sciences, Inc.). Membranes were washed stripped with 1 M NaOH for 10 min and reprobed with anti-ERK1/2 antibodies (1/20 000; Sigma). ERK activity was assayed subsequently by measuring the phosphorylation of myelin basic protein (MBP) as described elsewhere [20] . Brie¯y, after treatment with S100B for the times and concentrations indicated, cells were rinsed quickly in ice-cold phosphate buffer saline (PBS) and lysed in a buffer containing 20 mM Tris±HCl, pH 8.0, 2 mM EDTA, 50 mM glycerolphosphate, 1% (w/v) Triton X-100, 10% (v/v) glycerol, 1 mM sodium orthovanadate, 0.1 mg/ml 4-(2-aminoethyl) benzenesulfonyl¯uoride, 50 ìg/ml aprotinin, 2 ìM leupeptin, 2 ìM pepstatin A. The lysates were centrifuged in a microfuge for 5 min at 48C. Aliquots (20 ìl containing 5±10 ìg protein) of the supernatants were incubated at 308C for 20 min in a ®nal reaction solution containing 10 ìM ATP (0.2 ìCi [ 32 P]ATP; 3000 Ci/mmol; Amersham), 10 mM MgCl 2 and 0.13 mg/ml bovine brain MBP in a ®nal volume of 35 ìl. The speci®city of this method for measuring ERK activity in astrocytes was established by Neary and Zu [20] . Samples were analysed by 10% SDS±PAGE as described previously [18] . Phosphorylation was quanti®ed in a Cyclone PhosphorImager (Packard) and analysed with Optiquant software.
RESULTS
Astrocytes were treated with oxidized S100B (200 ng/ml) for 10 min and Western blots for phospho-ERK were performed. Oxidized S100B induced an increase in phospho-ERK, which, when corrected for total ERK, gave an increase of 59% for ERK1 and 66% for ERK2 (Fig. 1) . The effect of S100B on the activation of ERK was statistically signi®cant, but modest when compared with the activation given by ®broblast growth factor-2 (FGF-2, 25 ng/ml), which in parallel experiments induced an activation of 6.1 and 6.9 times the control for ERK1 and ERK2, respectively.
In order to con®rm these results as well as to evaluate whether the state of oxidation of the S100B affects ERK activation, as has been shown for glial proliferation [6±8], we measured the dose dependency of ERK activation by oxidized and non-oxidized S100B using the MBP phosphorylation assay (Fig. 2) . This assay was less sensitive than the assay based on immunodetection of phospho-ERK, but even so it was able to detect a signi®cant increase induced by S100B. Incubation of astrocytes with 2 ng/ml and 20 ng/ml of oxidized S100B for 10 min stimulated the activity of ERK towards MBP by 18% and 34% respectively. No further increase was observed at 200 ng/ml ( Fig. 2A,B) . Parallel experiments with FGF-2 induced activation of ERK towards MBP about 2.3 times the control (data from six independent experiments performed in duplicate). Nonoxidized S100B was markedly less active and only gave a signi®cant stimulation of ERK activity at 200 ng/ml (Fig.   2B ). Activation of ERK by S100B was maximal after 10 min and a variable or no activation was obtained with time points earlier than 10 min (Fig. 3) .
DISCUSSION
The effect of S100B shown here on the activation of ERK was small but statistically signi®cant, particularly when compared with the activation given by FGF-2. However, the activation of ERK by S100B was accompanied by a very slow decrease in activity, since ERK was still active 3 h after treatment with S100B (data not shown). The ERK activation induced in astrocytes by FGF-2 has a similar prolonged time course [15] .
The extracellular actions of S100B appear to be dependent on the presence of cysteine residues at positions 68 and 84 [7] and on the oxidation state of these residues [6, 8] . In the present study we con®rm that the activation of ERK by S100B is affected by its state of oxidation. Oxidized S100B was more potent in stimulating ERK compared to the reduced preparation, whose low stimulation possibly was due to small amount of oxidized form found in that preparation.
The signi®cant stimulation by extracellular S100B of ERK activity demonstrated here suggests that the effect of this protein on the proliferation of astrocytes may be mediated by the MAPK pathway. Consistent with this suggestion is the observation that extracellular S100B induces the transcription factors c-myc and c-fos in glial cells [6] . The upstream stages in the activation of ERK by S100B are unknown. In this regard a recent report demonstrating that a receptor for advanced glycation end products (RAGE) may be a receptor for S100B [21] is of particular interest since activation of RAGE in many cells including astrocytes triggers activation of the ERK pathway NEUROREPORT D. S. GONGALVES ET AL. [22, 23] . Another intriguing question is whether Ca 2 is involved in the upstream pathway as it has been proposed that the mitogenic action of S100B may be related to the ability of the protein to increase intracellular Ca 2 concentrations [24] . However, ERK activators in astrocytes, such as ATP, act independently of an increase in intracellular Ca 2 [17] .
CONCLUSION
This report shows, for the ®rst time, an effect of S100B on ERK activity, giving support to previous observations of the effect of this protein on glial proliferation [6] . These observations con®rm the importance of the oxidation state of cysteine residues in S100B for its extracellular activity [8] . Although we cannot exclude S100B involvement in other mechanisms of signal transduction, these results suggest that one of the extracellular actions of S100B could be mediated by the ERK. Fold Stimulation Fig. 3 . Time course of the activation of ERK by S100B. Primary cultures of hippocampal astrocytes were treated with S100B at 200 ng/ml for 0±30 min. ERK activity was analysed in described in Fig. 2 . Each value represents the mean AE s.e.m. from seven independent experiments performed in duplicate. Ã p , 0.05; ÃÃ p , 0.01, paired t-test. There was no signi®cant difference between the 10 and 30 min intervals.
